118 related articles for article (PubMed ID: 35023434)
1. Intradermal injection of icariin-HP-β-cyclodextrin improved traumatic brain injury via the trigeminal epineurium-brain dura pathway.
Yang W; Han YH; Wang HC; Lu CT; Yu XC; Zhao YZ
J Drug Target; 2022 Jun; 30(5):557-566. PubMed ID: 35023434
[TBL] [Abstract][Full Text] [Related]
2. A strategy for bypassing the blood-brain barrier: Facial intradermal brain-targeted delivery via the trigeminal nerve.
Yu XC; Yang JJ; Jin BH; Xu HL; Zhang HY; Xiao J; Lu CT; Zhao YZ; Yang W
J Control Release; 2017 Jul; 258():22-33. PubMed ID: 28476614
[TBL] [Abstract][Full Text] [Related]
3. The involvement of perivascular spaces or tissues in the facial intradermal brain-targeted delivery.
Yang W; Jin BH; Chen YJ; Cao C; Zhu JZ; Zhao YZ; Yu XC; Li FZ
Drug Deliv; 2019 Dec; 26(1):393-403. PubMed ID: 30929532
[TBL] [Abstract][Full Text] [Related]
4. Changes in the intestinal absorption mechanism of icariin in the nanocavities of cyclodextrins.
Zhang Y; Wang QS; Cui YL; Meng FC; Lin KM
Int J Nanomedicine; 2012; 7():4239-49. PubMed ID: 22904630
[TBL] [Abstract][Full Text] [Related]
5. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects.
Lima BDS; Campos CA; da Silva Santos ACR; Santos VCN; Trindade GDGG; Shanmugam S; Pereira EWM; Marreto RN; Duarte MC; Almeida JRGDS; Quintans JSS; Quintans LJ; Araújo AAS
Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery.
McCormack B; Gregoriadis G
Biochim Biophys Acta; 1996 Dec; 1291(3):237-44. PubMed ID: 8980638
[TBL] [Abstract][Full Text] [Related]
7. Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
Manta K; Papakyriakopoulou P; Chountoulesi M; Diamantis DA; Spaneas D; Vakali V; Naziris N; Chatziathanasiadou MV; Andreadelis I; Moschovou K; Athanasiadou I; Dallas P; Rekkas DM; Demetzos C; Colombo G; Banella S; Javornik U; Plavec J; Mavromoustakos T; Tzakos AG; Valsami G
Mol Pharm; 2020 Nov; 17(11):4241-4255. PubMed ID: 32986435
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of disulfiram inclusion complex embedded in hydroxypropyl-β-cyclodextrin on intracranial glioma-bearing male rats via intranasal route.
Qu Y; Sun X; Ma L; Li C; Xu Z; Ma W; Zhou Y; Zhao Z; Ma D
Eur J Pharm Sci; 2021 Jan; 156():105590. PubMed ID: 33065226
[TBL] [Abstract][Full Text] [Related]
9. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
[TBL] [Abstract][Full Text] [Related]
10. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.
Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G
J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689
[TBL] [Abstract][Full Text] [Related]
11. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of hydroxypropyl-β-cyclodextrin inclusion complex of eugenol: differential pulse voltammetry and (1)H-NMR.
Garg A; Gupta B; Prakash R; Singh S
Chem Pharm Bull (Tokyo); 2010 Oct; 58(10):1313-9. PubMed ID: 20930396
[TBL] [Abstract][Full Text] [Related]
13. Preparation of natural borneol/2-hydroxypropyl-β-cyclodextrin inclusion complex and its effect on the absorption of tetramethylpyrazine phosphate in mouse.
Su J; Chen J; Li L; Li B; Shi L; Zhang H; Ding X
Chem Pharm Bull (Tokyo); 2012; 60(6):736-42. PubMed ID: 22689424
[TBL] [Abstract][Full Text] [Related]
14. Solubility Enhancement of Myricetin by Inclusion Complexation with Heptakis-
Han D; Han Z; Liu L; Wang Y; Xin S; Zhang H; Yu Z
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991574
[TBL] [Abstract][Full Text] [Related]
15. The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-beta-cyclodextrin.
Gladys G; Claudia G; Marcela L
Eur J Pharm Sci; 2003 Nov; 20(3):285-93. PubMed ID: 14592694
[TBL] [Abstract][Full Text] [Related]
16. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of anticancer activity of honokiol by complexation with hydroxypropyl-β-cyclodextrin.
Wu W; Xue W
Colloids Surf B Biointerfaces; 2020 Dec; 196():111298. PubMed ID: 32798987
[TBL] [Abstract][Full Text] [Related]
18. Spray-dried mucoadhesive microparticles based on S-protected thiolated hydroxypropyl-β-cyclodextrin for budesonide nasal delivery.
Racaniello GF; Laquintana V; Summonte S; Lopedota A; Cutrignelli A; Lopalco A; Franco M; Bernkop-Schnürch A; Denora N
Int J Pharm; 2021 Jun; 603():120728. PubMed ID: 34029665
[TBL] [Abstract][Full Text] [Related]
19. Spray dried nanospheres for inclusion complexes of cefpodoxime proxetil with β-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin: improved dissolution and enhanced antibacterial activity.
Yurtdaş-Kırımlıoğlu G
Drug Dev Ind Pharm; 2021 Aug; 47(8):1261-1278. PubMed ID: 34606394
[TBL] [Abstract][Full Text] [Related]
20. Preparation of inclusion complex of apigenin-hydroxypropyl-β-cyclodextrin by using supercritical antisolvent process for dissolution and bioavailability enhancement.
Huang Y; Zu Y; Zhao X; Wu M; Feng Z; Deng Y; Zu C; Wang L
Int J Pharm; 2016 Sep; 511(2):921-30. PubMed ID: 27515291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
